Sign in to view content

PRN cycles of three monthly anti-VEGF injections in neovascular AMD: 12 and 24 months results.

Touka Banaee, MD

Video
Published 2019

Related

Wet AMD 1 Symposium
Annual Meeting Talks
2020
Prevalence and Risk Factors for Early Hydroxychloroquine Retinopathy
Bobeck S Modjtahedi, MD
On Demand Cases, Courses, and Papers
2017
Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019

Category: AMD-Neovascular

See more